Skip to main content
Fig. 1 | Annals of Clinical Microbiology and Antimicrobials

Fig. 1

From: High prevalence of Mucosa-Associated extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD)

Fig. 1

Frequency bar chart illustrating phenotypic antibiotic susceptibility profiles of mucosa-associated E. coli (blue chart) and K. pneumoniea (red chart) isolates from colonic biopsies of patients with IBD.

Abbreviations: AK, amikacin; AMP, ampicillin; ATM, aztreonam; CAZ, ceftazidime; CFM, cefixime; CIP, ciprofloxacin; CPM, cefepime; CRO, ceftriaxone; CTX, cefotaxime; ETP, ertapenem; FOX, cefoxitin; GAT, gatifloxacin; GM, gentamicin; IMI, imipenem; K, kanamycin; LEV, levofloxacin; MEM, meropenem; MFX, moxifloxacin; OF, ofloxacin; PRL, piperacillin; PTZ, piperacillin-tazobactam; TMP, trimethoprim; TOB, tobramycin; TS, trimethoprim-sulfamethoxazole

Back to article page